ResMed beat Wall Street estimates for second-quarter profit on Thursday, driven by strong demand for its devices used to manage sleep apnea, a common sleep disorder.

The global sleep software market valued at US$ 776.2 Million in 2023, is forecasted to grow at a robust CAGR of 10.1%, reaching US$ 878.9 Million in 2024 and an impressive US$ 1,569.2 Million by 2030.

An 8-week weight loss and lifestyle intervention improved vitamin D levels up to 6 months after treatment among men with OSA and high BMI.

The global sleep apnea devices market is set to expand at a steady CAGR of 9.5%, growing from USD 8.2 billion in 2023 to USD ...

On today’s CT BUZZ, Host Natasha Lubczenko sat down with Dr. Zach Korwin, owner of Sleep Stratford, to discuss an innovative ...

My wife, who bore the brunt of my transformation into a grumpy badger, was the first to suggest I get a sleep study. She’d ...

Obstructive Sleep Apnea (OSA) affects over 1 billion adults and children in worldwide, including an estimated 90 million people in the United States alone. (1-3) While continuous positive airway ...

Nocturnal asthma and sleep apnoea can both disrupt sleep but the two conditions are different and have different causes ...

For patients with obstructive sleep apnea (OSA), sleep surgery is associated with a significantly reduced risk for motor ...

According to statistics by the American Association of Medicine, the disorder sleep apnea affects approximately 30 million US ...

Taking a GLP-1 may help treat sleep apnea since obesity is one of many factors that increases your likelihood of the sleep ...

A new survey published today reveals that 70% of women report that their sleep is impacting their mental health, while a ...